Investor’s Alert: Ericsson (NASDAQ:ERIC), The Boeing Company (NYSE:BA), EMC Corporation (NYSE:EMC), Biogen Idec (NASDAQ:BIIB)

RBC Capital upgraded shares of Telefonaktiebolaget LM Ericsson (ADR) (NASDAQ:ERIC), from a sector perform rating to an outperform rating in a research note released on Wednesday morning,TheFlyOnTheWall.com reports. They currently have $16.00 target price on the stock, up from their previous target price of $13.00. Ericsson (ADR) (NASDAQ:ERIC), shares after opening at $12.85 moved to $12.96 on last trade day and at the end of the day closed at $12.91. Company price to sales ratio in past twelve months was calculated as 1.23 and price to cash ratio as 4.64. Ericsson (ADR) (NASDAQ:ERIC), showed a positive weekly performance of 1.25%.

Citigroup Inc. raised their price objective on shares of The Boeing Company (NYSE:BA) from $155.00 to $160.00 in a research note issued on Wednesday, Analyst Ratings Network reports. Citigroup Inc.’s price target would indicate a potential upside of 28.88% from the company’s current price. The Boeing Company (NYSE:BA), shares advanced 1.49% in last trading session and ended the day on $127.92. The Boeing Company (NYSE:BA), return on equity ratio is recorded as 47.20% and its return on assets is 5.00%. The Boeing Company (NYSE:BA), yearly performance is 51.38%.

EMC Corporation (NYSE:EMC), and IDC together announced how wireless technologies and software-defined business will transform the data storage market. It makes use of cloud based technology that allows opportunities to access large volume of information over the internet. So, the volume of data that could be analyzed in the digital universe will increase by ten folds in between 2013-2020 to 44 trillion GB. EMC Corporation (NYSE:EMC), shares moved down 0.30% in last trading session and was closed at $26.62, while trading in range of $ 26.20 – 26.69. EMC Corporation (NYSE:EMC), year to date (YTD) performance is 6.65%.

Biogen Idec Inc (NASDAQ:BIIB), has announced that it will be presenting new data on its current and future neurological disease therapies at the American Academy of Neurology (AAN) annual meeting. Biogen Idec Inc (NASDAQ:BIIB), weekly performance is 1.11%. On last trading day company shares ended up $290.54. Biogen Idec Inc (NASDAQ:BIIB), distance from 50-day simple moving average (SMA50) is -9.37%. Analysts mean target Price for the company is $346.84.